Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
3.230
-0.720 (-18.23%)
At close: Mar 31, 2025, 4:00 PM
3.378
+0.148 (4.57%)
Pre-market: Apr 1, 2025, 5:26 AM EDT

Telomir Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.2700-
Cash & Short-Term Investments
1.2700-
Cash Growth
102753.86%-13.25%--
Prepaid Expenses
0.060--
Other Current Assets
-0.430.05-
Total Current Assets
1.320.440.05-
Long-Term Deferred Charges
-4.34--
Total Assets
1.324.770.05-
Accounts Payable
0.590.710.40.02
Short-Term Debt
0.090.630.580.12
Total Current Liabilities
0.681.340.990.14
Total Liabilities
0.681.340.990.14
Additional Paid-In Capital
31.2417.50.060.06
Retained Earnings
-30.6-14.06-0.99-0.14
Comprehensive Income & Other
----0.06
Shareholders' Equity
0.643.44-0.94-0.14
Total Liabilities & Equity
1.324.770.05-
Total Debt
0.090.630.580.12
Net Cash (Debt)
1.17-0.63-0.58-0.12
Net Cash Per Share
0.04-0.02-0.02-
Filing Date Shares Outstanding
29.7629.6127.1-
Total Common Shares Outstanding
29.7628.6126.83-
Working Capital
0.64-0.9-0.94-0.14
Book Value Per Share
0.020.12-0.03-
Tangible Book Value
0.643.44-0.94-0.14
Tangible Book Value Per Share
0.020.12-0.03-
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q